Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib

INTRODUCTION: This comprehensive observational study aimed to gain insight into adherence to nilotinib and the effect of (non)adherence on exposure (C(min)) and treatment outcomes. METHODS: Chronic myeloid leukemia (CML) patients using nilotinib were followed for 12 months. Adherence was measured by...

Descripción completa

Detalles Bibliográficos
Autores principales: Boons, Christel C. L. M., Timmers, Lonneke, Janssen, Jeroen J. W. M., Westerweel, Peter E., Blijlevens, Nicole M. A., Smit, Willem M., Bartelink, Imke H., Wilschut, Janneke A., Swart, Eleonora L., Hendrikse, N. Harry, Hugtenburg, Jacqueline G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419465/
https://www.ncbi.nlm.nih.gov/pubmed/32488333
http://dx.doi.org/10.1007/s00228-020-02910-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419465/
https://www.ncbi.nlm.nih.gov/pubmed/32488333
http://dx.doi.org/10.1007/s00228-020-02910-3

Ejemplares similares